Women's health company lands $21M Series D for uterine fibroid ablation

February 20, 2013 by MassDevice staff

California company Gynesonics lands a $21 million Series D funding round in support of its VizAblate ultrasound-guided uterine fibroid ablation system.

Gynesonics logo

Women's health devices maker Gynesonics landed $21 million in new financing in supports of its ultrasound-guided uterine fibroid ablation system, the company announced today.

The California company plans to use the funds to further clinical and commercial progress for its VizAblate system, a minimally invasive method for treating uterine fibroids and an alternative to hysterectomy.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.